NWMP
PFE icon

Noble Wealth Management PBC’s Pfizer PFE Stock Holding History

Noble Wealth Management PBC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$735 Sell
29
-1,140
-98% -$29.8K ﹤0.01% 492
2024
Q4 		$31K Buy
+1,169
New +$31.7K 0.02% 237

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Noble Wealth Management PBC's PFE Position: Q1 2025 in Review

Noble Wealth Management PBC reduced its Pfizer (PFE) stake by 98% in Q1 2025, selling an estimated $29.8K and leaving 29 shares worth $735. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Noble Wealth Management PBC first reported a position in PFE in Q4 2024 and has held it in 2 quarters since. The position peaked at $31K in Q4 2024. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Noble Wealth Management PBC held 29 shares of Pfizer worth $735 as of Q1 2025.
  • Noble Wealth Management PBC sold 1,140 Pfizer shares in Q1 2025, an estimated $29.8K.
  • Pfizer made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q1 2025, its #492 holding.
  • Noble Wealth Management PBC first reported a position in Pfizer in Q4 2024 and has held it in 2 quarters since.
  • Noble Wealth Management PBC's Pfizer position peaked at $31K in Q4 2024.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Noble Wealth Management PBC's 13F filing for Q1 2025, filed 15 Apr 2025.